Hasbani G, Jawad A, Uthman I. Update on the management of colchicine resistant familial mediterranean fever (FMF) [J]. Orphanet J Rare Dis,2019, 14(1): 224.
[7]
Alghamdi M. Familial mediterranean fever, review of the literature [J]. Clin Rheumatol, 2017, 36(8): 1707-1713.
[8]
Özen S, Batu E D, Demir S. Familial mediterranean fever: recent developments in pathogenesis and new recommendations for management [J]. Front Immunol, 2017, 8:253.
Topaloglu R, Batu E D, YildizÇ, et al. Familial mediterranean fever patients homozygous for E148Q variant may have milder disease [J]. Int J rheum Dis, 2018, 21(10): 1857-1862.
[11]
Manna R, Rigante D. Familial mediterranean fever: assessing the overall clinical impact and formulating treatment plans [J]. Mediterr J Hematol Infec Dis, 2019, 11(1): e2019027.
Skendros P, Papagoras C, Mitroulis I, et al. Autoinflammation: lessons from the study of familial mediterranean fever [J]. J Autoimmun, 2019, 104:102305.
[14]
Yalçinkaya F, Ozen S, Ozçakar Z B, et al. A new set of criteria for the diagnosis of familial Mediterranean fever in childhood [J]. Rheumatology (Oxford), 2009, 48(4): 395-398.
[15]
Sari I, Birlik M, Kasifoglu T. Familial mediterranean fever: an updated review [J]. Eur J Rheumato, 2014, 1(1): 21-33.
[16]
Ciaula A, Stella A, Bonfrate L, et al. Gut microbiota between environment and genetic background in familial mediterranean fever (FMF) [J]. Genes(Basel),2020, 11(9):1041.
2021, Vol. 32 
